ISCB - ETF AI Analysis
Top Page
iShares Morningstar Small-Cap ETF (ISCB)
Rating:67Neutral
Price Target:―
Positive Factors
Broad Small-Cap Diversification
The fund spreads its investments across many small U.S. companies and sectors, which helps reduce the impact of any single stock or industry.
Strong Recent Performance
The ETF has shown steady gains over the past month, quarter, and year-to-date, indicating positive recent momentum in its holdings.
Very Low Expense Ratio
The fund charges a low fee, which helps investors keep more of the returns generated by the portfolio over time.
Negative Factors
Heavy U.S. Concentration
With almost all assets in U.S. stocks, the fund offers little geographic diversification and is highly tied to the U.S. economy.
Exposure to Volatile Sectors
Significant weights in sectors like industrials, financials, health care, and technology can make the fund more sensitive to economic and market swings.
Mixed Performance Among Top Holdings
While several top positions have delivered strong gains, at least one key holding has shown weak performance, which can create uneven results within the portfolio.
ISCB vs. SPDR S&P 500 ETF (SPY)
AUM246.45M
RegionNorth America
Expense Ratio0.04%
Beta1.02
IssueriShares
Inception DateJun 28, 2004
Dividend Yield1.44%
Asset ClassEquity
Index TrackedMorningstar US Small Cap Extended Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume4,297
30 Day Avg. Volume5,922
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
81.37Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering1549
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ISCB Summary
The iShares Morningstar Small-Cap ETF (ISCB) is a fund that follows the Morningstar US Small Cap Extended Index, focusing on smaller U.S. companies across many sectors like industrials, financials, health care, and technology. It holds hundreds of stocks, including well-known names like Moderna and Albemarle, giving you broad exposure to the small-cap part of the market in a single investment. Someone might invest in ISCB to seek long-term growth and diversify beyond large, well-known companies. A key risk is that small-cap stocks can be more volatile, so the ETF’s price can move up and down more sharply than the overall market.
How much will it cost me?The iShares Morningstar Small-Cap ETF (ISCB) has an expense ratio of 0.04%, which means you’ll pay $0.40 per year for every $1,000 invested. This is lower than average because it’s a passively managed fund that tracks an index, keeping costs down.
What would affect this ETF?The iShares Morningstar Small-Cap ETF (ISCB) could benefit from economic growth and innovation in sectors like technology and healthcare, which make up a significant portion of its holdings. However, small-cap stocks are often more sensitive to interest rate hikes and economic slowdowns, which could negatively impact the ETF's performance. Additionally, its focus on U.S.-based companies means it may be affected by domestic regulatory changes or geopolitical events.
ISCB Top 10 Holdings
ISCB’s story is all about U.S. small caps with an industrial and health-care tilt. Lumentum has been one of the fund’s real engines lately, riding strong momentum, while CF Industries and Ovintiv are also pulling their weight as cyclical names rebound. On the health-care side, Moderna is climbing again, helping offset more mixed, stop-and-go performance from Exact Sciences. Albemarle, tied to the choppy EV and materials space, has been more of a wobbling wheel than a growth engine, but no single stock dominates, keeping name-specific risk in check.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Lumentum Holdings | 0.89% | $2.14M | $50.43B | 960.43% | 61 Neutral | |
| Cf Industries Holdings | 0.36% | $860.81K | $19.19B | 62.67% | 72 Outperform | |
| Exact Sciences | 0.35% | $848.30K | $20.03B | 129.96% | 70 Outperform | |
| ATI | 0.35% | $838.61K | $19.42B | 172.48% | 78 Outperform | |
| Albemarle | 0.33% | $807.63K | $18.47B | 102.04% | 58 Neutral | |
| Moderna | 0.32% | $778.66K | $20.29B | 57.32% | 59 Neutral | |
| RBC Bearings | 0.30% | $723.37K | $16.79B | 60.93% | 77 Outperform | |
| Ovintiv | 0.30% | $721.64K | C$22.16B | 37.41% | 60 Neutral | |
| Nextpower Inc | 0.30% | $721.23K | $16.98B | 158.39% | 78 Outperform | |
| Huntington Ingalls | 0.29% | $702.95K | $16.01B | 102.50% | 69 Neutral |
ISCB Technical Analysis
Negative
―
Price Trends
67.87
Negative
66.07
Negative
63.25
Positive
Market Momentum
-1.08
Positive
31.10
Neutral
11.67
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ISCB, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 66.75, equal to the 50-day MA of 67.87, and equal to the 200-day MA of 63.25, indicating a neutral trend. The MACD of -1.08 indicates Positive momentum. The RSI at 31.10 is Neutral, neither overbought nor oversold. The STOCH value of 11.67 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ISCB.
ISCB Peer Comparison
Comparison Results
Performance Comparison
ISCB
iShares Morningstar Small-Cap ETF
63.55
7.89
14.18%
OUSM
OShares U.S. Small-Cap Quality Dividend ETF
―
―
―
GSSC
Goldman Sachs Activebeta U.S. Small Cap Equity ETF
―
―
―
BBSC
JPMorgan BetaBuilders U.S. Small Cap Equity ETF
―
―
―
JHSC
John Hancock Multifactor Small Cap ETF
―
―
―
SFLO
VictoryShares Small Cap Free Cash Flow ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents